Koordinierende/r Wissenschaftler

Krankheitsbereich

Beteiligte DZL-Standorte

Titel

Behr J / Günther A Interstitielle (Diffuse Parenchymatöse) Lungenerkrankung alle Exploratory efficacy and safety study of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF in lung fibrosis)
Griese M Interstitielle (Diffuse Parenchymatöse) Lungenerkrankung alle Hydroxychloroquine (HCQ) in pediatric ILD (= children‘s interstitial lung disease; chILD)
Herold S Pneumonie und Akutes Lungenversagen BREATH, UGMLC GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEsoration (GI-HOPE)
Herold S / Lohmeyer J / Welte T Pneumonie und Akutes Lungenversagen BREATH, UGMLC Promotion of host defense and alveolar barrier regeneration by inhaled GM-CSF in patients with pneumonia-associated ARDS
Heußel C Lungenkrebs BREATH, CPC-M, TLRC, UGMLC Early response capturing in the treatment of adenocarcinoma
Jobst B COPD alle Imaging disease progression in COP
Kreuter M / Vogelmeier C / Herth F COPD TLRC, UGMLC Exploring efficacy of peridontal treatment on systemic inflammation and for prevention of exacerbations in patients with COPD: A multi-center, prospective, randomized, controlled, parallel-group pilot study
Reck M / Ammerpohl O / Barreto G Lungenkrebs alle Monitoring of patients with NLCLC – epigenetic analysis of liquid biopsies and RNA-analysis in exhaled breath condensates
Schulz H / Meiners S / Vogelmeier C / Behr J COPD CPC-M, UGMLC Proteasom Function as a Bio-Marker for COPD
Seeger W / Ghofrani A / Gall H Pulmonale Hypertonie BREATH, UGMLC Influence of specific PAH medication on right ventricular function in patients with pulmonary arterial hypertension
Tümmler B Cystische Fibrose BREATH, TLRC, UGMLC Orkambifacts – Intestinal current measurements (ICM) to evaluate the activation of mutant CFTR in treated with lumacaftor in combination with ivacaftor.
Vogel-Claussen J Radiologie / Pulmonale Hypertronie BREATH, CPC-M, UGMLC, TLRC Change-MRI – Phase III diagnostic trial to demonstrate that functional lung MRI can replace VQ-SPECT in a diagnostic strategy for patients with suspected CTEPH.
Vogelmeier C  COPD ARCN, BREATH, UGMLC Clinical study to investigate safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD – A randomised, double-blind, parallel, multicentre, phase IIa pilot study
Zabel P / Herth F / König I / Rabe K / Welte T  COPD ARCN, BREATH, TLRC Evaluation of non-invasive pursed-lip breathing ventilation in advanced COPD

 

Wir nutzen Cookies um unsere Website zu verbessern. Mit der Auswahl „Ok“ erlauben Sie die Verwendung von Cookies.
Weitere Informationen entnehmen Sie bitte unserer Datenschutzerklärung.
Ok